You are here

Award Data

For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. STTR Phase I: Simplification AI for Workforce Upskilling

    SBC: Choosito!            Topic: EA

    This STTR Phase I project addresses the challenge of upskilling the workforce by developing novel personalized content simplification technology. It will build a novel digital binder tool with an AI empowered content selection and simplification capability. The magnitude and urgency of the workforce upskilling problem require an immediate and robust solution. Corporations are desperate to find and ...

    STTR Phase I 2019 National Science Foundation
  2. STTR Phase I: Bioparticle delivery of dsRNA: A novel pest management solution for control of Western flower thrips

    SBC: AGROSPHERES INC.            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is to develop a targeted biological pesticide for control of the western flower thrips to reduce the impact of one of the most economically devastating agricultural pests. Thrips are a global agricultural pest that carry a family of viruses that can infect more than 1,000 species of plants including a ...

    STTR Phase I 2019 National Science Foundation
  3. STTR Phase I: Increased Scalability for Blockchains applied to Healthcare

    SBC: Simplyvital Health, Inc.            Topic: OT

    The broader impact of this Small Business Innovation Research (SBIR) project is to drive down healthcare costs by enabling access to data through blockchain technology. The healthcare system is plagued by inefficiencies, many of which boil down to the inability to access the right data at the right time because of technological and business barriers. Leveraging blockchain for data access can drive ...

    STTR Phase I 2019 National Science Foundation
  4. STTR Phase I: Minimally-invasive reversible thermal nerve block for relief of severe pain

    SBC: Thermaquil, Inc.            Topic: MD

    This SBIR Phase I project will develop and test a minimally invasive method and device that blocks pain. The device will offer patients and physicians a new non-addictive way of controlling severe pain with the ultimate goal of reducing or eliminating society's need for opioids and other narcotics. More than 350,000 Americans died from opioid overdose during 1999-2016, and the societal cost of opi ...

    STTR Phase I 2019 National Science Foundation
  5. STTR Phase I: Developing a platform for superior predictive analysis of HERG Ion Channel-Drug Interactions for the Comprehensive In-vitro Proarrhythmia Assay (CiPA)

    SBC: Cytocybernetics Inc            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be to improve the safety testing of new drugs for approval by the FDA. By decreasing the time and costs associated with safety testing, the product will make all classes of new drugs safer, less expensive and available to patients sooner. All new drugs must demonstrate that they are safe. One com ...

    STTR Phase I 2019 National Science Foundation
  6. STTR Phase I: Building with Carbon: Improving Construction Materials with Nanocarbon Additives from Natural Gas

    SBC: H Quest Vanguard Inc            Topic: MI

    The broader impact/commercial potential of this project is the improvements to the strength, durability, and longevity of concrete infrastructure and construction materials with novel graphene-rich carbon nanomaterial additives. Advancement of this technology area (advanced materials/nanomaterials for infrastructure applications) will directly reduce the costs of construction and maintenance ($165 ...

    STTR Phase I 2019 National Science Foundation
  7. STTR Phase II: Novel real-time particulate matter (PM) sensor for air quality measurements

    SBC: Potsdam Sensors LLC            Topic: CT

    The broader impact/commercial potential of this STTR project is in the reduction of healthcare-associated infections (HAIs) by proactively responding to data from novel sensors. In addition, the technology being developed in this project can also help measure airborne particle concentrations in other environments. The successful completion of this proposal will result in improved public health fro ...

    STTR Phase II 2019 National Science Foundation
  8. POC Blood Coagulopathy Monitor

    SBC: CFD Research Corporation            Topic: DHA19A001

    Traumatic injuries account for 30% of all life years lost in the US and is the leading cause of death for people under 46 years of age. Uncontrolled bleeding or hemorrhage constitute 30-40% of trauma related deaths and are considered to be a major cause o

    STTR Phase I 2019 Department of DefenseDefense Health Agency
  9. STTR Phase I: Portable Ultra-Resolution EEG for Improved Diagnosis and Treatment of Brain Disorders: Instrumentation and Algorithms

    SBC: Precision Neuroscopics LLC            Topic: BM

    This SBIR Phase I project will advance novel techniques for developing high-resolution noninvasive brain imaging systems, capable of recording unprecedented spatiotemporal resolution inferences of the brain activity for a portable system. These systems leverage novel fundamental analysis and results, and experimental demonstrations, that show that spatial resolution of Electroencephalography (EEG) ...

    STTR Phase I 2019 National Science Foundation
  10. STTR Phase I: Sustained Delivery of Peptides with Inverse Flash Nanoprecipitation

    SBC: Optimeos Life Sciences, Inc.            Topic: BM

    This STTR Phase I project aims to pioneer a novel approach for the sustained delivery of peptide therapeutics using nano-composite microparticles. Peptide therapeutics tend to suffer from rapid enzymatic degradation and clearance, with half-lives on the order of minutes, and require frequent injections. The goal of a sustained release formulation is to reduce the frequency of injections by slowly ...

    STTR Phase I 2019 National Science Foundation
US Flag An Official Website of the United States Government